Drug establishmentActive, Registered FY2026FDA warning letter on file

Orean Personal Care Ltd.

Orean Personal Care Ltd. is an FDA-registered drug establishment (FEI 3010999645) located in . The facility is active, registered for FY2026. Its most recent FDA inspection on record (2026-02-20) was classified OAI. FDA has issued 1 warning letter(s) to this facility.

FDA warning letter

Aug 29, 2024
CGMP/Finished Pharmaceuticals/Adulterated

A warning letter is FDA's formal notice of significant violations that require prompt correction. It can hold up product approvals, trigger import alerts, and put supply agreements at risk until the issues are resolved and FDA closes it out.

Establishment record

FEI Number
3010999645
Address
Unit E1 Stubs Beck Lane West 26 Industrial Estate, ,
Establishment type
Drug establishment
Products / operations
Manufacturing, Packaging
Registration status
Active, Registered FY2026

Verify this record on FDA.gov ›

Inspection history

Inspections on file
Feb 20, 2026 · Official Action Indicated (OAI)
Mar 15, 2024 · Official Action Indicated (OAI)
Sep 8, 2017 · Voluntary Action Indicated (VAI)
Form 483 observations
Mar 15, 2024, 7 observations: Equipment Design, Size and Location; Handling and Storage to Prevent Contamination; Investigations of discrepancies, failures
Sep 8, 2017, 7 observations: Calibration/Inspection/Checking not done; Drug product sample; Valid stability test methods

Questions

Is Orean Personal Care Ltd. registered with the FDA?

Yes. Orean Personal Care Ltd. is an FDA-registered drug establishment (FEI 3010999645) in . Its current registration status is Active, Registered FY2026.

Has Orean Personal Care Ltd. received an FDA warning letter?

Yes. FDA issued a warning letter to Orean Personal Care Ltd.; the most recent is dated Aug 29, 2024 (CGMP/Finished Pharmaceuticals/Adulterated).

What does Orean Personal Care Ltd. do?

Orean Personal Care Ltd.'s FDA-registered operations are: Manufacturing, Packaging.

Related facilities

Source: FDA public data · status as of 2026-06-06

The Quality Brief

Every new FDA drug and device warning letter and recall, summarized once a week. Free.